Position in ENLV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$106,232
-$15,040 QoQ
Shares Held
12,877
+48.1% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 25 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENLV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. ENLV ranks #308 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ENLV
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $106,232 | 193,150 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $121,272 | 130,401 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $59,823 | 85,098 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $130 | 125 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $3,409 | 3,044 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $213 | 220 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,233 | 1,054 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $243 | 145 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $718 | 266 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,324 | 838 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,200 | 838 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,050 | 838 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,547 | 647 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $3,187 | 750 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,491 | 1,215 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $34,451 | 6,163 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $20,600 | 3,296 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $36,407 | 3,685 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,983 | 897 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $34,767 | 3,135 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $26,326 | 3,123 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||